Recent Updates
Recently added Catalysts
AORT Positive Sentiment Score: 70/100

Artivion Announces Release Date and Teleconference Call Details for Fourth Quarter and Full Year 2024 Financial Results Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, announced today that fourth quarter and full...

Key Takeaway: Artivion, Inc. announced the release date for its fourth quarter and full year 2024 financial results, scheduled for February 24, 2025. Following the release, a teleconference call will be held at 4:30 p.m. ET, allowing for discussion of the results and a Q&A session with the company's CEO. This event underscores the company's commitment to engaging with investors and providing updates on its financial performance and strategic initiatives.

Market Sentiment Analysis

POSITIVE FACTORS

  • Artivion is set to release its financial results for Q4 and full year 2024, indicating operational transparency.
  • The upcoming teleconference call provides an opportunity for stakeholders to engage directly with the CEO.
  • Artivion's focus on addressing aortic disease highlights its commitment to improving cardiac and vascular health.

Full Press Release Details

ATLANTA , Feb. 10, 2025 /PRNewswire/ -- Artivion, Inc. (NYSE: AORT ), a leading cardiac and vascular surgery company focused on aortic disease, announced today that fourth quarter and full year 2024 financial results will be released on Monday, February 24, 2025 after the market closes. On that day, the Company will hold a teleconference call and live webcast at 4:30 p.m. ET to discuss the results, followed by a question and answer session hosted by Pat Mackin , Chairman, President and Chief Executive Officer of Artivion.
To listen to the live teleconference, please dial 201-689-8261 a few minutes prior to 4:30 p.m. ET . The teleconference replay will be available approximately one hour following the completion of the event and can be accessed by calling (toll free) 877-660-6853 or 201-612-7415. The conference number for the replay is 13749878.
The live webcast and replay can be accessed on the Investors section of the Artivion website at www.artivion.com and by selecting Webcasts & Presentations. In addition, a copy of the earnings press release, which will contain financial and statistical information for the completed quarter and full year, can be accessed in the Investors section of the Artivion website.
About Artivion, Inc. Headquartered in suburban Atlanta, Georgia , Artivion, Inc. is a medical device company focused on developing simple, elegant solutions that address cardiac and vascular surgeons' most difficult challenges in treating patients with aortic diseases. Artivion's four major groups of products include: aortic stent grafts, surgical sealants, On-X mechanical heart valves, and implantable cardiac and vascular human tissues. Artivion markets and sells products in more than 100 countries worldwide. For additional information about Artivion, visit our website, www.artivion.com .
Contacts:
Artivion Lance A. Berry Executive Vice President & Chief Financial Officer Phone: 770-419-3355 Gilmartin Group LLC Brian Johnston / Laine Morgan Phone: 332-895-3222 [email protected]
SOURCE Artivion, Inc.

21 %

Frequently Asked Questions

When will Artivion release its Q4 2024 financial results?

Artivion will release its fourth quarter 2024 financial results on February 24, 2025.

How can I access the live teleconference on the financial results?

Dial 201-689-8261 a few minutes before 4:30 p.m. ET on February 24, 2025.

Where can I find the financial press release?

The earnings press release will be available in the Investors section of Artivion's website.

Who will host the Q&A session after the financial results?

Pat Mackin, the Chairman and CEO of Artivion, will host the Q&A session.

What products does Artivion focus on developing?

Artivion develops products like aortic stent grafts, surgical sealants, and heart valves.

Last updated: Feb 10, 2025